Diabetes-related foot disease

Podcast & Infographic

Click to listen the Podcast

Diabetes-related foot disease

E-learning Modules

Launch: 16 September 2024


Approximately 18.6 million people worldwide are affected by a diabetic foot ulcer each year [Armstrong, 2023]. Neurological, vascular and biomechanical factors contribute to diabetic foot ulceration [Armstrong, 2023]. Best results are achieved with multidisciplinary care, typically consisting of podiatrists, infectious disease specialists and vascular surgeons [Armstrong, 2023].

Data from the United States suggest that amputation rates among those with both diabetes mellitus and peripheral artery disease (PAD) have remained stable or even increased in high-risk subgroups (residents of rural areas, African-American and Native American patients, those of low socioeconomic status) [Schaper, 2023; Armstrong, 2023]. Thus, the burden of amputation is severe, with 5-year mortality rates exceeding those of many malignancies. There are also financial costs to the person involved and considerable burden for those caring for patients with PAD and diabetes mellitus, including family, healthcare professionals and facilities, and society in general [Barnes, 2020].

The high-risk subgroups identified by Barnes et al highlight the societal groups who are least likely to receive or engage with preventive and interventional cardiovascular care, and represent an educational need for healthcare professionals. Additional studies have shown that there are variations in the degree of foot-care knowledge and foot-care practices and no studies on the prevalence of knowledge and practice regarding specific exercises for the legs and feet [Manickum, 2021].

Structured, organized, repeated education for patients, their family, and healthcare professionals about foot care plays an important role in preventing diabetes-related foot ulcers [Schaper, 2023] as well as a number of further factors related to life-style and poor self-care [Jalilian, 2020].

This podcast will not only cover the prevalence, patients at high-risk and the educational complexities associated with diabetes-related foot disease, it will also cover the treatment of diabetic foot ulcers [Bolton, 2022] including the effect of metformin [Love, 2022].

Learning Objectives

After listening to this podcast, participants will be able to:

Target Audience

Clinicians involved in endocrinology, particularly diabetes, pre-diabetes; fertility and pregnancy management, obesity management and general practice; some content of interest to midwives and nurses involved in pre-natal and post-natal care; some content of interest to vascular specialists and podiatrists.


English with voice-over into Spanish and Chinese


Alberto Piaggesi

Alberto Piaggesi

Director of the Diabetic Foot Section
Department of Endocrinology and Metabolism
University of Pisa
Pisa, Italy

Final Programme

Download Final Programme

· Alberto Piaggesi ·

Alberto Piaggesi graduated in Medicine and Surgery at the Medical School, University of Pisa where he then specialized both in Internal Medicine and Endocrinology and Metabolism. Since 1991, he has held a post of Consultant at the Department of Endocrinology and Metabolism, University of Pisa, where he is the Director of the Diabetic Foot Section, a tertiary referral center for Tuscany and Central Italy. He is Professor of Endocrinology and Metabolism at the Medical and Podiatry School, and Professor of Lower Limb Complications Management at the School of Specialization in Endocrinology and Metabolism, University of Pisa. He has authored more than 100 publications, books and book chapters on many aspects of the diabetic foot. He serves as a referee for peer-review international journals, and he is a member of the editorial board for the International Consensus Guidelines for the Management of the Diabetic Foot. Prof. Piaggesi served as Scientific Member and then President of the European Wound Management Association (EWMA) and he was a founder of the International Association of Diabetic Foot Surgeons (i-ADFS). He is the scientific lead responsible for the organization of the Italian and the International Residential Course on the Management of Lower Limb Complications of Diabetes and he has trained over 1000 diabetologists, podiatrists, nurses and orthotists during his 25-year tenure.

· Martin O. Savage ·

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.  His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 60 countries and has published 482 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.